Quarterly report pursuant to Section 13 or 15(d)

Summary of Stock Option Activity (Details)

v3.23.1
Summary of Stock Option Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]    
Number of options, outstanding, beginning balance 6,724,402  
Weighted average exercise price, beginning balance $ 0.95  
Weighted average contractual term 7 years 9 months 7 years 11 months 26 days
Aggregate Intrinsic value outstanding, beginning [1] $ 2,773  
Number of options, outstanding, Granted  
Weighted average exercise price,Granted  
Number of options, outstanding,Exercised  
Weighted average exercise price,Exercised  
Number of options, outstanding, Forfeited (54,498)  
Weighted average exercise price, Forfeited $ 1.53  
Number of options, outstanding,Ending Balance 6,669,904 6,724,402
Weighted average exercise price,Ending Balance $ 0.95 $ 0.95
Aggregate Intrinsic value outstanding Ending [1] $ 2,773
Number of options, outstanding,Exercisable Ending Balance 5,961,568  
Weighted average exercise price,Exercisable Ending Balance $ 0.96  
Weighted average contractual term, exercisable 7 years 7 months 9 days  
Aggregate Intrinsic value Exercisable, Ending [1]  
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2021 and March 31, 2022, respectively.